Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Berger

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
The New England Journal of Medicine|December 19, 2008
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndromeJ Curtis Nickel, John N Krieger, Mary McNaughton-Collins, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
Rapid development of two factor IXa inhibitors from hit to leadDann L Parker, Shawn Walsh, Bing Li, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2017
Investigation of piperazine benzamides as human β<sub>3</sub> adrenergic receptor agonists for the treatment of overactive bladderBart H Harper, Liping Wang, Cheng Zhu, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery of Broad-Spectrum Herpes Antiviral Oxazolidinone Amide Derivatives and Their Structure-Activity RelationshipsMichael A Plotkin, Marc Labroli, Jeffrey Schubert, et al.
Journal of Medicinal Chemistry|January 21, 2014
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladderChristopher R Moyes, Richard Berger, Stephen D Goble, et al.
Geburtshilfe Und Frauenheilkunde|August 20, 2019
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of MembranesRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|May 11, 2023
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of MembranesRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Correction: Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of MembranesRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|May 8, 2023
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm BirthRichard Berger, Harald Abele, Franz Bahlmann, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
The New England Journal of Medicine|December 19, 2008
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndromeJ Curtis Nickel, John N Krieger, Mary McNaughton-Collins, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
Rapid development of two factor IXa inhibitors from hit to leadDann L Parker, Shawn Walsh, Bing Li, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2017
Investigation of piperazine benzamides as human β<sub>3</sub> adrenergic receptor agonists for the treatment of overactive bladderBart H Harper, Liping Wang, Cheng Zhu, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery of Broad-Spectrum Herpes Antiviral Oxazolidinone Amide Derivatives and Their Structure-Activity RelationshipsMichael A Plotkin, Marc Labroli, Jeffrey Schubert, et al.
Journal of Medicinal Chemistry|January 21, 2014
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladderChristopher R Moyes, Richard Berger, Stephen D Goble, et al.
Geburtshilfe Und Frauenheilkunde|August 20, 2019
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of MembranesRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|May 11, 2023
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of MembranesRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Correction: Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of MembranesRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|May 8, 2023
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm BirthRichard Berger, Harald Abele, Franz Bahlmann, et al.
Pageof 8